New, Improved Treatments for Chagas Disease: From the R&D Pipeline to the Patients

2009/07/06 by Isabela Ribeiro, Ann-Marie Sevcsik, Fabiana Alves +5 · 3 citations
Immunology and Microbiology · Medicine · #Chagas disease #Demography #Disease #Economic growth #Environmental health #Geography #Immunology #Latin Americans #Malaria #Medicine #Mortality rate #Neglected tropical diseases #Parasites and Host Interactions #Political science #Population #Poverty #Productivity #Public health #Research on Leishmaniasis Studies #Socioeconomic status #Socioeconomics #Transmission (telecommunications) #Tropical disease #Trypanosoma species research and implications

paper · pdf · doi:10.1371/journal.pntd.0000484

openalex publication_date 2009/07/06 · openalex created_date 2016/06/24 · openalex updated_date 2026/07/15

Abstract

New, Improved Treatments for Chagas Disease: From the R&D\n Pipeline to the Patients

Citations

• Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem
• Neglected Disease Research and Development: How Much Are We Really Spending?
• Measuring the Burden of Neglected Tropical Diseases: The Global Burden of Disease Framework

Cited by

• Chagas Disease Diagnostic Applications
• Rapid immunochromatographic tests for the diagnosis of chronic Chagas disease in at-risk populations: A systematic review and meta-analysis
• Chagas: Time to Treat campaign [wikipedia]

Related

• Why hasn’t there been more progress in new Chagas disease drug discovery?
• Status of vaccine research and development of vaccines for Chagas disease
• A therapeutic preconceptional vaccine against Chagas disease: A novel indication that could reduce congenital transmission and accelerate vaccine development
• In Silico Drug Repositioning for Chagas Disease
• Chagas Disease in the United States: a Public Health Approach